Zeria Pharmaceutical Co., Ltd. (4559) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Zeria Pharmaceutical Co., Ltd. Company Snapshot

Business Description:

Zeria Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector. Zeria Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company. The Company operates in three business segments. The Ethical Pharmaceutical segment is principally involved in the manufacture, purchase and sale of ethical pharmaceutical products. The Consumer Healthcare segment is involved in the manufacture, purchase and sale of health food products related to over the counter (OTC) drugs and self medication, import and export of raw materials, as well as production and sale of cosmetics, among others. The Others segment is engaged in the insurance agency and real estate businesses, as well as the purchase and sale of promotional items. In our complete report available for purchase the company is compared to: Towa Pharmaceutical Company Limited, Aska Pharmaceutical Company Limited and Torii Pharmaceutical Co., Ltd..

Zeria Pharmaceutical Co., Ltd.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 1,323.00
(Figures in Japanese Yen)

1 Week	0.6%	13 Weeks	-2.0%

4 Weeks	8.4%	52 Weeks	29.8%

Zeria Pharmaceutical Co., Ltd. Key Data:

Ticker:	4559	Country:	JAPAN

Exchanges:	TYO	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2011 Sales	49,482,197,000 (Year Ending Jan 2012).	Employees:	1,287

Currency:	Japanese Yen	Market Cap:	54,705,007,476

Fiscal Yr Ends:	March	Shares Outstanding:	41,348,052

Share Type:	Common	Closely Held Shares:	17,012,000

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.